Infinity Pharmaceuticals Articles
Infinity amends PI3K-delta, gamma accord with Millennium
28 December 2012
Infinity plunges as it halts two saridegib trials
19 June 2012
Showing 1-4 of 4 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
